VEGFA and Hepatic fibrosis: Pioglitazone shows inhibitory effects on the level of vascular endothelial growth factor (VEGF), which is related to many ischemic and inflammatory disorders, and the main factor contributing to the progression of liver fibrosis and hepatic carcinogenesis [15].